Masanori Shigyo

Hypermethylation of an E-Cadherin ( <i>CDH</i> 1) Promoter Region in High Grade Transitional Cell Carcinoma of the Bladder Comprising Carcinoma In Situ

Yohei Horikawa, Kokichi Sugano, Masanori Shigyo et al. · The Journal of Urology · 2003 · 53 citations

Clinical significance of definite muscle layer in TUR specimen for evaluating progression rate in T1G3 bladder cancer: multicenter retrospective study by the Sapporo Medical University Urologic Oncology Consortium (SUOC)

Tetsuya Shindo, Naoya Masumori, Hiroshi Kitamura et al. · World Journal of Urology · 2013 · 36 citations

Urological Research, Urology, Urologic Cancer Epidemiology +8

Paclitaxel, ifosfamide, and nedaplatin as second‐line treatment for patients with metastatic urothelial carcinoma: A phase II study of the SUOC group

Hiroshi Kitamura, Keisuke Taguchi, Yasuharu Kunishima et al. · Cancer Science · 2011 · 30 citations · Full text

Tin Therapy, Urology, Oncology +14

Allelic loss on chromosome 9 in bladder cancer tissues and urine samples detected by blunt-end single-strand DNA conformation polymorphism

Masanori Shigyo, Kokichi Sugano, Noriko Fukayama et al. · International Journal of Cancer · 1998 · 24 citations

Massive hematuria after cystoscopy in a patient with an internal iliac artery aneurysm

Ichiya Honma, Yoshio Takagi, Masanori Shigyo et al. · International Journal of Urology · 2002 · 19 citations